Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer’s disease

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259 · see citing works

HTSeq—a Python framework to work with high-throughput sequencing data

Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464 · see citing works

The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments

Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231 · see citing works

Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation

McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · see citing works

Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt

Durinck, S., Spellman, P. T., Birney, E., & Huber, W. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.97 · Cited by 4,081 · see citing works

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works

Pericytes regulate the blood–brain barrier

Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · see citing works

Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease

Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works

Development, maintenance and disruption of the blood-brain barrier

Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452 · see citing works

Immunopathology of multiple sclerosis

Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215 · see citing works

Immune attack: the role of inflammation in Alzheimer disease

Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · see citing works

The Cellular Phase of Alzheimer’s Disease

De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · see citing works

How neuroinflammation contributes to neurodegeneration

Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · see citing works

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · see citing works

Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease

Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · see citing works

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature · doi:10.1038/s41586-019-0924-x · Cited by 1,310 · see citing works

APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2247-3 · Cited by 1,281 · see citing works

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202 · see citing works

Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins

Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works

Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease

Gate, D., Saligrama, N., Leventhal, O., Yang, A. C., Unger, M. S., Middeldorp, J., Chen, K., Lehallier, B., Channappa, D., De Los Santos, M. B., et al. (2020) · Nature · doi:10.1038/s41586-019-1895-7 · Cited by 992 · see citing works

Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways

Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947 · see citing works

Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice

Lazarov, O., Robinson, J., Tang, Y.-P., Hairston, I. S., Korade-Mirnics, Z., Lee, V. M.-Y., Hersh, L. B., Sapolsky, R. M., Mirnics, K., & Sisodia, S. S. (2005) · Cell · doi:10.1016/j.cell.2005.01.015 · Cited by 885 · see citing works

Co-expression of multiple transgenes in mouse CNS: a comparison of strategies

Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 819 · see citing works

TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function

Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763 · see citing works

Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution

Mathys, H., Adaikkan, C., Gao, F., Young, J. Z., Manet, E., Hemberg, M., De Jager, P. L., Ransohoff, R. M., Regev, A., & Tsai, L.-H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.039 · Cited by 740 · see citing works

Vascular dysfunction—The disregarded partner of Alzheimer's disease

Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · see citing works

NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease

Lian, H., Yang, L., Cole, A., Sun, L., Chiang, A. C.-A., Fowler, S. W., Shim, D. J., Rodriguez-Rivera, J., Taglialatela, G., Jankowsky, J. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.018 · Cited by 697 · see citing works

The dual nature of type I and type II interferons

Lee, A. J., & Ashkar, A. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02061 · Cited by 690 · see citing works

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689 · see citing works

Vascular endothelial–cadherin is an important determinant of microvascular integrity in vivo

Corada, M., Mariotti, M., Thurston, G., Smith, K., Kunkel, R., Brockhaus, M., Lampugnani, M. G., Martín-Padura, I., Stoppacciaro, A., Ruco, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9815 · Cited by 677 · see citing works

Alzheimer’s disease: A matter of blood–brain barrier dysfunction?

Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672 · see citing works

P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660 · see citing works

Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

Minter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., Ward, J. F., Holtzman, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30028 · Cited by 655 · see citing works

Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease

Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649 · see citing works

Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5

Taddei, A., Giampietro, C., Conti, A., Orsenigo, F., Breviario, F., Pirazzoli, V., Potente, M., Daly, C., Dimmeler, S., & Dejana, E. (2008) · Nature Cell Biology · doi:10.1038/ncb1752 · Cited by 648 · see citing works

Aging-induced type I interferon response at the choroid plexus negatively affects brain function

Baruch, K., Deczkowska, A., David, E., Castellano, J. M., Miller, O., Kertser, A., Berkutzki, T., Barnett-Itzhaki, Z., Bezalel, D., Wyss-Coray, T., et al. (2014) · Science · doi:10.1126/science.1252945 · Cited by 615 · see citing works

Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease

van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2016) · Radiology · doi:10.1148/radiol.2016152244 · Cited by 601 · see citing works

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease

Lian, H., Litvinchuk, A., Chiang, A. C.-A., Aithmitti, N., Jankowsky, J. L., & Zheng, H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2117-15.2016 · Cited by 597 · see citing works

Neuroinflammatory astrocyte subtypes in the mouse brain

Hasel, P., Rose, I. V. L., Sadick, J. S., Kim, R. D., & Liddelow, S. A. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00905-6 · Cited by 586 · see citing works

Microglial regional heterogeneity and its role in the brain

Tan, Y.-L., Yuan, Y., & Tian, L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0609-8 · Cited by 571 · see citing works

Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease

Roy, E. R., Wang, B., Wan, Y.-W., Chiu, G., Cole, A., Yin, Z., Propson, N. E., Xu, Y., Jankowsky, J. L., Liu, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133737 · Cited by 563 · see citing works

Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke

Kang, L., Yu, H., Yang, X., Zhu, Y., Bai, X., Wang, R., Cao, Y., Xu, H., Luo, H., Lu, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16191-y · Cited by 546 · see citing works

Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier

Storck, S. E., Meister, S., Nahrath, J., Meißner, J. N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R. E., Bouter, Y., Prikulis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81108 · Cited by 477 · see citing works

Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1

Yousef, H., Czupalla, C. J., Lee, D., Chen, M. B., Burke, A. N., Zera, K. A., Zandstra, J., Berber, E., Lehallier, B., Mathur, V., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0440-4 · Cited by 442 · see citing works

TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease

Griciuc, A., Patel, S., Federico, A. N., Choi, S. H., Innes, B. J., Oram, M. K., Cereghetti, G., McGinty, D., Anselmo, A., Sadreyev, R. I., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.010 · Cited by 378 · see citing works

Microglia-Mediated Synapse Loss in Alzheimer's Disease

Rajendran, L., & Paolicelli, R. C. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1136-17.2017 · Cited by 355 · see citing works

Interferon-Induced Ifit Proteins: Their Role in Viral Pathogenesis

Fensterl, V., & Sen, G. C. (2014) · Journal of Virology · doi:10.1128/jvi.02744-14 · Cited by 341 · see citing works

Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice

Lazarov, O., Lee, M., Peterson, D. A., & Sisodia, S. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09785.2002 · Cited by 302 · see citing works

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease

Bennett, R. E., Robbins, A. B., Hu, M., Cao, X., Betensky, R. A., Clark, T., Das, S., & Hyman, B. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710329115 · Cited by 299 · see citing works

Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation

Jambusaria, A., Hong, Z., Zhang, L., Srivastava, S., Jana, A., Tóth, P. T., Dai, Y., Malik, A. B., & Rehman, J. (2020) · eLife · doi:10.7554/elife.51413 · Cited by 291 · see citing works

Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes

Blanchard, J. W., Bula, M., Davila-Velderrain, J., Akay, L. A., Zhu, L., Frank, A., Victor, M. B., Bonner, J. M., Mathys, H., Lin, Y.-T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0886-4 · Cited by 283 · see citing works

Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging

Propson, N. E., Roy, E. R., Litvinchuk, A., Köhl, J., & Zheng, H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140966 · Cited by 258 · see citing works

Interferon β for Multiple SclerosisPreprint

Jakimovski, D., Kolb, C., Ramanathan, M. K., Zivadinov, R., & Weinstock‐Guttman, B. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a032003 · Cited by 170 · see citing works

Identification of Genes Selectively Regulated by IFNs in Endothelial Cells

Indraccolo, S., Pfeffer, U., Minuzzo, S. A., Esposito, G., Roni, V., Mandruzzato, S., Ferrari, N., Anfosso, L., Dell’Eva, R., Noonan, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1122 · Cited by 158 · see citing works

Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models

Sebastian Monasor, L., Müller, S. A., Colombo, A. V., Tanrioever, G., König, J., Roth, S., Liesz, A., Berghofer, A., Piechotta, A., Prestel, M., et al. (2020) · eLife · doi:10.7554/elife.54083 · Cited by 147 · see citing works

β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease

Li, J., Li, M., Ge, Y., Chen, J., Ma, J., Wang, C., Sun, M., Wang, L., Yao, S., & Yao, C. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00807-5 · Cited by 145 · see citing works

Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model

Takeda, S., Sato, N., Ikimura, K., Nishino, H., Rakugi, H., & Morishita, R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.010 · Cited by 135 · see citing works

Sex dimorphism profile of Alzheimer’s disease-type pathologies in an APP/PS1 mouse model

Jiao, S.-S., Bu, X.-L., Liu, Y.-H., Zhu, C., Wang, Q.-H., Shen, L.-L., Liu, C.-H., Wang, Y.-R., Yao, X.-Q., & Wang, Y.-J. (2016) · Neurotoxicity Research · doi:10.1007/s12640-015-9589-x · Cited by 129 · see citing works

Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology

Deczkowska, A., Baruch, K., & Schwartz, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.006 · Cited by 125 · see citing works

Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia

Dodiya, H. B., Lutz, H. L., Weigle, I. Q., Patel, P., Michalkiewicz, J., Roman-Santiago, C. J., Zhang, C. M., Liang, Y., Srinath, A., Zhang, X., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20200895 · Cited by 120 · see citing works

Interferon‐β stabilizes barrier characteristics of brain endothelial cells in vitro

Kraus, J., Ling, A. K., Hamm, S., Voigt, K., Oschmann, P., & Engelhardt, B. (2004) · Annals of Neurology · doi:10.1002/ana.20161 · Cited by 105 · see citing works

Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic function

Willemsen, M. H., Ba, W., Wissink-Lindhout, W. M., de Brouwer, A. P. M., Haas, S. A., Bienek, M., Hu, H., Vissers, L. E. L. M., van Bokhoven, H., Kalscheuer, V. M., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102182 · Cited by 99 · see citing works

Blood will out: vascular contributions to Alzheimer’s disease

Strickland, S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97509 · Cited by 92 · see citing works

Gain‐of‐Function of Olig Transcription Factors Enhances Oligodendrogenesis and Myelination

Maire, C., Wegener, A., Kerninon, C., & Oumesmar, B. N. (2010) · Stem Cells · doi:10.1002/stem.480 · Cited by 74 · see citing works

Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells

Kuboyama, K., Fujikawa, A., Suzuki, R., & Noda, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2127-15.2015 · Cited by 71 · see citing works

The impact of interferon-β treatment on the blood–brain barrier

Kraus, J., & Oschmann, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.008 · Cited by 58 · see citing works

Concurrent cell type–specific isolation and profiling of mouse brains in inflammation and Alzheimer’s disease

Swartzlander, D. B., Propson, N. E., Roy, E. R., Saito, T., Saido, T. C., Wang, B., & Zheng, H. (2018) · JCI Insight · doi:10.1172/jci.insight.121109 · Cited by 54 · see citing works

Increase of white matter string vessels in Alzheimer's disease

CHALLA, V. R., Thore, C. R., Moody, D. M., Anstrom, J. A., & Brown, W. R. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6404 · Cited by 50 · see citing works

Interferon-β stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro

Kraus, J., Voigt, K., Schuller, A., Scholz, M., Kim, K., Schilling, M., Schäbitz, W., Oschmann, P., & Engelhardt, B. (2008) · Multiple Sclerosis · doi:10.1177/1352458508088940 · Cited by 50 · see citing works

Cardiac endothelial cells maintain open chromatin and expression of cardiomyocyte myofibrillar genes

Yucel, N. D., Axsom, J., Yang, Y., Li, L., Rhoades, J. H., & Arany, Z. P. (2020) · eLife · doi:10.7554/elife.55730 · Cited by 34 · see citing works

In vivo characterization of spontaneous microhemorrhage formation in mice with cerebral amyloid angiopathy

van Veluw, S. J., Frosch, M. P., Scherlek, A. A., Lee, D. C., Greenberg, S. M., & Bacskai, B. J. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19899377 · Cited by 26 · see citing works

Role of neuroinflammation in neurodegeneration development

Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works

Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation

Biswas, K. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578180 · Cited by 159 · see citing works

Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice

Yoon, S.-H., Kim, C., Lee, E., Lee, C., Lee, K.-S., Lee, J., Park, H., Choi, B., Hwang, I., Kim, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56097-1 · Cited by 68 · see citing works

STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges

Yang, K., Tang, Z., Xing, C., & Yan, N. (2023) · Neuron · doi:10.1016/j.neuron.2023.10.014 · Cited by 63 · see citing works

Neutrophil extracellular traps in central nervous system pathologies: A mini review

Shafqat, A., Eddin, A. N., Adi, G., Al-Rimawi, M., Rab, S. A., Abu-Shaar, M., Adi, K., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1083242 · Cited by 62 · see citing works

The protective roles of citrus flavonoids, naringenin, and naringin on endothelial cell dysfunction in diseases

Adetunji, J. A., Fasae, K. D., Awe, A., Paimo, O. K., Adegoke, A. M., Akintunde, J. K., & Sekhoacha, M. P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17166 · Cited by 56 · see citing works

The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia

Albertini, G., Zielonka, M., Cuypers, M., Snellinx, A., Xu, C., Poovathingal, S. K., Wojno, M., Davie, K., van Lieshout, V., Craessaerts, K., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02125-8 · Cited by 47 · see citing works

Experimental Type 2 diabetes and lipotoxicity-associated neuroinflammation involve mitochondrial DNA-mediated cGAS/STING axis: implication of Type-1 interferon response in cognitive impairment

Kumari, P., Sood, A., Fernandes, V., Khan, I., Khatri, D. K., & Singh, S. B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03933-y · Cited by 24 · see citing works

Endothelial type I interferon response and brain diseases: identifying STING as a therapeutic target

Duarte, N., Shafi, A. M., Penha‐Gonçalves, C., & Pais, T. F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1249235 · Cited by 20 · see citing works

Cellular junction dynamics and Alzheimer’s disease: a comprehensive review

Asghari, K., Niknam, Z., Mohammadpour-Asl, S., & Chodari, L. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09242-w · Cited by 20 · see citing works

Microglia drive diurnal variation in susceptibility to inflammatory blood-brain barrier breakdown

Lawrence, J. H., Patel, A. D., King, M. W., Nadarajah, C. J., Daneman, R., & Musiek, E. S. (2024) · JCI Insight · doi:10.1172/jci.insight.180081 · Cited by 21 · see citing works

Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model

Pan, T.-T., Sun, Y., Shi, Y.-F., Zhao, M., Khan, N. U., Chen, H., Ji, W., Li, J., Han, L., & Ma, Q. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01840-5 · Cited by 20 · see citing works

Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions

Chaudhuri, S., Cho, M., Stumpff, J., Bice, P. J., İş, Ö., Ertekin‐Taner, N., Saykin, A. J., & Nho, K. T. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00798-0 · Cited by 18 · see citing works

Pericytes: The forgotten controllers of a functional blood–brain barrier

Roedel, M., Brooks, N., & Lamb, T. J. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013145 · Cited by 17 · see citing works

Emerging roles for innate and adaptive immunity in tauopathies

Johnson, A. M., & Lukens, J. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116232 · Cited by 17 · see citing works

The role of interferon signaling in neurodegeneration and neuropsychiatric disorders

Sirkis, D. W., Oddi, A. P., Jonson, C., Bonham, L. W., Hoang, P. T., & Yokoyama, J. S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1480438 · Cited by 15 · see citing works

Restoring brain barriers: an innovative approach for treating neurological disorders

Lemarchant, S., Engelhardt, B., Cicchetti, F., Bix, G. J., Janus, A., Godfrin, Y., Blasco, H., Campbell, M., & Jacquet, A. D. R. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00688-z · Cited by 16 · see citing works

Brain endothelial cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling pathway in aging and neurodegeneration

Sun, B., Li, L., & Luo, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00442 · Cited by 15 · see citing works

In sickness and in health—Type I interferon and the brain

Cao, W. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1403142 · Cited by 14 · see citing works

Insight into cerebral microvessel endothelial regulation of cognitive impairment: A systematic review of the causes and consequences

Liu, C., Chen, X., Yang, S., Wang, X., Sun, P., Wang, J., & Zhu, G. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115116 · Cited by 13 · see citing works

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease

Wasielewska, J. M., Szostak, K., McInnes, L. E., Quek, H., Chaves, J. C. S., Liddell, J. R., Koıstınaho, J., Oikari, L. E., Donnelly, P. S., & White, A. R. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00743 · Cited by 12 · see citing works

The Ever‐Expanding Influence of the Endothelial Nitric Oxide Synthase

Rafea, R., Siragusa, M., & Fleming, I. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70029 · Cited by 11 · see citing works

Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus

Lin, S. L., & Carroll, M. C. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102608 · Cited by 8 · see citing works

Deficiency of Smooth Muscle Adar1 Exacerbates Vascular Remodeling and Pulmonary Hypertension

Kim, Y., Maroli, G., Woodcock, C.-­. C., Kim, H., Liu, Y., Klouda, T., Li, Y., Li, Q., Hao, Y. T., Schumacher, V., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326235 · Cited by 8 · see citing works

From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene associated with autism and alzheimer's disease

Fu, Y., Xie, G.-M., Liu, R.-Q., Xie, J., Zhang, J., & Zhang, J. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148992 · Cited by 7 · see citing works

SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease

Vavougios, G. D., Mavridis, T., Doskas, T. K., Papaggeli, O., Foka, P., & Hadjigeorgiou, G. M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050277 · Cited by 5 · see citing works

Noncanonical functions of adhesion proteins in inflammation

Wang, R., Shu, R. R., & Seldin, L. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00292.2024 · Cited by 5 · see citing works

Multifactorial glial responses and their contributions to Alzheimer's disease continuum

Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4 · see citing works

Type-1 interferons associated with microglial-mediated neuroinflammation in Alzheimer’s disease

Shippy, D. C., Sande, M. L., & Ulland, T. K. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03828-w · Cited by 3 · see citing works

Type I IFN in Glomerular Disease: Scarring beyond the STING

Jiménez‐Uribe, A. P., Mangos, S., & Hahm, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052497 · Cited by 3 · see citing works

SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model

Lioudyno, M., Sevrioukov, E. A., Olivarria, G. M., Hitchcock, L., Javonillo, D. I., Campos, S. M., Rivera, I., Wright, S. T., Head, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02895-2 · Cited by 2 · see citing works

Effect of Puerarin on Chronic Alcoholic Encephalopathy by Modulating the “Microbiota‐Gut‐Brain Axis” Lipopolysaccharides/Toll‐Like Receptors 4/Nuclear Factor Kappa‐B Inflammatory Pathway

Zhang, L., Li, B., Ye, F., Li, L.-Z., Xiong, S., & Lei, S. S. (2026) · Phytotherapy Research · doi:10.1002/ptr.70197 · Cited by 1 · see citing works

Microbiota-specific serum IgG links gut and joints through immune–endothelial crosstalk in arthritis

Schmid, E., Otterbein, N., Ariyeloye, S., Danzer, H., Frech, M., Naschberger, E., Muñoz‐Becerra, M., Sarter, K., Schett, G. A., Kastbom, A., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1821367 · Cited by 1 · see citing works

Lorlatinib protects dopaminergic neurons by inhibiting ALK-mediated neuroinflammation in a mouse model of Parkinson’s disease

Kim, D.-Y., Kim, S.-E., Park, J.-E., Leem, Y., Park, J., & Kim, H.-S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119596 · Cited by 1 · see citing works

Neurovascular unit senescence as a driver of blood–brain barrier dysfunction in Alzheimer’s disease：Mechanisms, consequences, and therapeutic implications

Yao, M., Liu, A., Xing, L., Song, J., Yang, Y., Yue, X., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103260 · Cited by 1 · see citing works

Immune Responses to RNA Viruses in the Central Nervous System

Nguyen, B. H., Schultz, K. L. W., & Griffin, D. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00249-0 · Cited by 1 · see citing works

Inhibition of β-catenin signaling by Amyloid-β in endothelial cells impairs vascular barrier integrityPreprint

Leasure, J. W., Mai, T., Fogel, A. V., Danos-Diaz, P., Wang, L., Sanborn, M. A., Ye, Z., Kim, Y.-M., Wang, X., Flores, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.622172 · Cited by 1 · see citing works

The Alzheimer’s therapeutic Lecanemab induces an amyloid-clearing program in microgliaPreprint

Albertini, G., Zielonka, M., Marie-Lynn, C., Snellinx, A., Xu, C., Suresh, P., Marta, W., Davie, K., Veerle, V. L., Craessaerts, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666347 · Cited by 1 · see citing works

Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease

Miao, J., Wang, J., Li, Y., Zhang, H., Zhang, Y., Li, Q., Xiao, B., Zhou, W., & Guo, J. (2026) · Advanced Science · doi:10.1002/advs.77929

Neurological Impact of Type I Interferon Dysregulation

Mylonas, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006023

Distinct and Combined Interferon-ɑ/β-receptor-1 Loss in Neurons and Astrocytes Disrupt Brain Energy Metabolism and Drive Parkinsonian DementiaPreprint

Villanueva, E. B., Zebec, Z., Lundstrøm, J., Andersen, J. V., Qvist, F. L., Westi, E. W., Marín, A., Jimenez‐Duran, G., Riera-Ponsati, L., Tresse, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.14.670043

Discovery of disease-associated cellular states using ResidPCA in single-cell RNA and ATAC sequencing data

Carver, S., Taraszka, K., Groha, S., & Gusev, A. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100538

Blood–brain barrier dysfunction and peripheral immune activation in Alzheimer’s disease: an inflammation-centered review

Yang, Z., Xiao, Z., Huang, B., & Wang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1955233

Targeting TLR4/NF-κB/NLRP3 signaling with 6-hydroxyflavanone mitigates amyloid-β-induced Alzheimer’s disease in mice

Rakshit, D., Nema, M., & Mishra, A. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119833

The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer’s disease

Mesquita, S. D., Ferreira, A. C., Gao, F., Coppola, G., Geschwind, D. H., Sousa, J. C., Correia‐Neves, M., Sousa, N., Palha, J. A., & Marques, F. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.008 · Cited by 86 · see citing works

The role of the blood-brain barrier in a mouse model of Alzheimer's disease

Dominguez-Belloso, A. (2021) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)

Mechanisms of Vascular Dysfunction in Alzheimer’s Disease

Leasure, J. W. (2024) · Figshare · doi:10.25417/uic.29049815

Inhibition of β-catenin signaling by Amyloid-β in endothelial cells impairs vascular barrier integrityPreprint

Leasure, J. W., Mai, T., Fogel, A. V., Danos-Diaz, P., Wang, L., Sanborn, M. A., Ye, Z., Kim, Y.-M., Wang, X., Flores, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.622172 · Cited by 1 · see citing works

Inflammatory reprogramming of human brain endothelial cells compromises blood–brain barrier integrity in Alzheimer’s diseasePreprint

Pinals, R. L., Islam, R., King, O., Choi, A., Kang, E., Nakano, M., Tuyeras, A., Naomi, M. T., Ngo, A., Jiang, A. Y. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.26.678918 · Cited by 3 · see citing works